●
QNCX
Quince Therapeutics, Inc.
$197K
Cluster buy
Discretionary Insider Activity
Date:
08/08/2023
Insiders:
Thye Dirk, director, and 2 others
Prior trend:
23 months of no clear discretionary insider activity

Summary

A $197K cluster buy for Quince Therapeutics, Inc. (QNCX) on 08/08/2023 after 23 months of no clear discretionary insider activity trend.

Reports

Action Amount Date Insider Role(s) SEC Filing No
● Buy $99K 08/09/2023 Thye Dirk Director, Chief Executive Officer 0001209191-23-045235
● Buy $10K 08/09/2023 McLoughlin Margaret Director 0001209191-23-045231
● Buy $88K 08/09/2023 Hannah Brendan Chief Business Officer 0001209191-23-045234

Transactions

Action Amount Date Insider Security Type SEC Code
● Buy $99K 08/08/2023 Thye Dirk Common Stock Discretionary Purchase
● Buy $10K 08/08/2023 McLoughlin Margaret Common Stock Discretionary Purchase
● Buy $88K 08/08/2023 Hannah Brendan Common Stock Discretionary Purchase

Stats

Prior max multiple:
6.4
Prior median multiple:
9.4

Metadata

Signal ID:
HKhFTSN8zCA4kGg4
Detected on:
08/07/2023